Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 145 results found. Search for [ experimental drug ]

Results 1 to 21 of 145
BusinessToday.In
November 22, 2020
USFDA Commissioner Stephen Hahn said that USFDA has been preparing for review of EUAs for COVID-19 vaccines for the past several months and requests will be processed \"as expeditiously as possible\"


Reuters
November 22, 2020
The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


BusinessToday.In
November 21, 2020
Pfizer that its EUA submission is supported by solicited safety data from a randomised subset of approximately 8,000 participants aged 18 years or above and unsolicited safety data from approximately 38,000 trial participants


BusinessToday.In
November 18, 2020
Pfizer and BioNTech informed that primary efficacy analysis of their coronavirus vaccine candidate showed that it was 95 per cent effective beginning 28 days after the first dose


Reuters
November 18, 2020
Johnson & Johnson's chief scientist said the drugmaker must provide safety data to the US Food and Drug Administration for at least one-half of trial participants for a duration of two months after they receive the vaccine


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


Reuters
November 12, 2020
Moderna said the information is being prepared for submission to the trial's independent data safety monitoring board, which will look at the results and make a recommendation


Reuters
November 11, 2020
Scientists, public health officials and investors welcomed the first successful interim data from a large-scale clinical test as a watershed moment that could help turn the tide of the pandemic if the full trial results pan out


Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


Vivek Dubey
October 31, 2020
J&J's COVID-19 vaccine uses a cold virus to deliver coronavirus genetic material to spur an immune response with the help of a platform - called AdVac, also used in the Ebola vaccine


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


BusinessToday.In
October 22, 2020
Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days


BusinessToday.In
October 20, 2020
Speaking during The Wall Street Journal's annual Tech Live conference on October 19, Moderna CEO Stephane Bancel said if satisfactory interim results from the study take longer to get, government authorisation of the COVID-19 vaccine may not happen until early next year


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


PTI
October 14, 2020
Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


PAGES 1 OF 8  12345